Long-Term Follow-Up Study of AAV2hAQP1 for Radiation Induced Xerostomia

Not Recruiting

Trial ID: NCT05060341

Age - 18 Years-81 Years Condition - Head and Neck Cancers (H&N) Gender - ALL Accepting Healthy Volunteers - No

Purpose

This study is a long-term follow-up study for patients who have been administered AAV2hAQP1 in the Phase 1 Open-Label, Dose Escalation Study to Determine the Optimal Dose, Safety, and Activity in Subjects with Radiation Induced Parotid Gland Hypofunction and Xerostomia

Official Title

Long-Term Follow-Up Study of Participants Enrolled in the MGT016 Phase 1, Open-Label, Dose-Escalation Study of AAV2hAQP1 for Radiation-Induced Parotid Gland Hypofunction and Xerostomia

Stanford Investigator(s)

Dyani Gaudilliere
Dyani Gaudilliere

Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery

Eligibility

Inclusion Criteria:

1. Are willing and able to provide informed consent
2. Received AAV2hAQP1 administered via Stensen's duct to a single or both parotid glands in the prior open-label, Phase 1, dose-escalation study (Study MGT016)
3. Are willing and able to adhere to the protocol and long-term follow-up

Exclusion Criteria:

1. Subjects unwilling or unable to meet with the requirements of the study will be excluded

View More
View Less

Not Recruiting

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Somayeh H. Ahmad
650-441-0405

New Trial Alerts

©2024 Stanford Medicine